Mutations in the factor V, prothrombin and MTHFR genes are not risk factors for recurrent fetal loss

A. Dilley, Carlos Benito, W. C. Hooper, H. Austin, C. Miller, M. El-Jamil, S. Cottrell, J. Benson, B. L. Evatt, A. Patterson-Barnett, D. Eller, C. Philipp

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Objective: Recurrent fetal loss, defined as the occurrence of three or more consecutive spontaneous abortions regardless of previous live birth, is a condition that affects about 2% of all reproductive-aged women. The role of gene mutations in recurrent pregnancy loss is not fully understood. The present research examined the relationship between factor V Leiden, factor V HR2, prothrombin G20210A and MTHFR and recurrent fetal loss in a case-control study. Methods: Women aged 22-45 with a history of three or more fetal losses, being seen at a perinatal medicine clinic in New Jersey or Georgia, were eligible as cases. Overall, the study consisted of 60 women with three or more fetal losses and 92 women with at least one successful pregnancy. Results: Factor V HR2 and MTHFR were not related to recurrent fetal loss. The prothrombin G20210A mutation appeared to confer an elevation in risk but the association was based upon small numbers and was not statistically significant (OR 4.8, 95% CI 0.50-47.2). Cases were 90% less likely to have the factor V Leiden mutation than controls (OR 0.10, 95% CI 0.01-0.81). Conclusions: Our study did not demonstrate that women who are carriers of the factor V, prothrombin, or MTHFR mutations are at higher risk of recurrent fetal loss than women without these mutations. In regards to factor V Leiden, the prevalence in our cases (1.7%) was not statistically different from the known population prevalence of 5%. However, the high prevalence in our controls (14%) was unusual. Factor V Leiden may protect against bleeding in early pregnancy.

Original languageEnglish (US)
Pages (from-to)176-182
Number of pages7
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume11
Issue number3
DOIs
StatePublished - Jan 1 2002
Externally publishedYes

Fingerprint

Factor V
Prothrombin
Mutation
Genes
Pregnancy
Live Birth
Spontaneous Abortion
Case-Control Studies
Medicine
Hemorrhage
factor V Leiden
Research
Population

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Dilley, A. ; Benito, Carlos ; Hooper, W. C. ; Austin, H. ; Miller, C. ; El-Jamil, M. ; Cottrell, S. ; Benson, J. ; Evatt, B. L. ; Patterson-Barnett, A. ; Eller, D. ; Philipp, C. / Mutations in the factor V, prothrombin and MTHFR genes are not risk factors for recurrent fetal loss. In: Journal of Maternal-Fetal and Neonatal Medicine. 2002 ; Vol. 11, No. 3. pp. 176-182.
@article{d7115dc60bdd4b7982d016831ff19e8c,
title = "Mutations in the factor V, prothrombin and MTHFR genes are not risk factors for recurrent fetal loss",
abstract = "Objective: Recurrent fetal loss, defined as the occurrence of three or more consecutive spontaneous abortions regardless of previous live birth, is a condition that affects about 2{\%} of all reproductive-aged women. The role of gene mutations in recurrent pregnancy loss is not fully understood. The present research examined the relationship between factor V Leiden, factor V HR2, prothrombin G20210A and MTHFR and recurrent fetal loss in a case-control study. Methods: Women aged 22-45 with a history of three or more fetal losses, being seen at a perinatal medicine clinic in New Jersey or Georgia, were eligible as cases. Overall, the study consisted of 60 women with three or more fetal losses and 92 women with at least one successful pregnancy. Results: Factor V HR2 and MTHFR were not related to recurrent fetal loss. The prothrombin G20210A mutation appeared to confer an elevation in risk but the association was based upon small numbers and was not statistically significant (OR 4.8, 95{\%} CI 0.50-47.2). Cases were 90{\%} less likely to have the factor V Leiden mutation than controls (OR 0.10, 95{\%} CI 0.01-0.81). Conclusions: Our study did not demonstrate that women who are carriers of the factor V, prothrombin, or MTHFR mutations are at higher risk of recurrent fetal loss than women without these mutations. In regards to factor V Leiden, the prevalence in our cases (1.7{\%}) was not statistically different from the known population prevalence of 5{\%}. However, the high prevalence in our controls (14{\%}) was unusual. Factor V Leiden may protect against bleeding in early pregnancy.",
author = "A. Dilley and Carlos Benito and Hooper, {W. C.} and H. Austin and C. Miller and M. El-Jamil and S. Cottrell and J. Benson and Evatt, {B. L.} and A. Patterson-Barnett and D. Eller and C. Philipp",
year = "2002",
month = "1",
day = "1",
doi = "10.1080/jmf.11.3.176.182",
language = "English (US)",
volume = "11",
pages = "176--182",
journal = "Journal of Maternal-Fetal and Neonatal Medicine",
issn = "1476-7058",
publisher = "Informa Healthcare",
number = "3",

}

Dilley, A, Benito, C, Hooper, WC, Austin, H, Miller, C, El-Jamil, M, Cottrell, S, Benson, J, Evatt, BL, Patterson-Barnett, A, Eller, D & Philipp, C 2002, 'Mutations in the factor V, prothrombin and MTHFR genes are not risk factors for recurrent fetal loss', Journal of Maternal-Fetal and Neonatal Medicine, vol. 11, no. 3, pp. 176-182. https://doi.org/10.1080/jmf.11.3.176.182

Mutations in the factor V, prothrombin and MTHFR genes are not risk factors for recurrent fetal loss. / Dilley, A.; Benito, Carlos; Hooper, W. C.; Austin, H.; Miller, C.; El-Jamil, M.; Cottrell, S.; Benson, J.; Evatt, B. L.; Patterson-Barnett, A.; Eller, D.; Philipp, C.

In: Journal of Maternal-Fetal and Neonatal Medicine, Vol. 11, No. 3, 01.01.2002, p. 176-182.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mutations in the factor V, prothrombin and MTHFR genes are not risk factors for recurrent fetal loss

AU - Dilley, A.

AU - Benito, Carlos

AU - Hooper, W. C.

AU - Austin, H.

AU - Miller, C.

AU - El-Jamil, M.

AU - Cottrell, S.

AU - Benson, J.

AU - Evatt, B. L.

AU - Patterson-Barnett, A.

AU - Eller, D.

AU - Philipp, C.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Objective: Recurrent fetal loss, defined as the occurrence of three or more consecutive spontaneous abortions regardless of previous live birth, is a condition that affects about 2% of all reproductive-aged women. The role of gene mutations in recurrent pregnancy loss is not fully understood. The present research examined the relationship between factor V Leiden, factor V HR2, prothrombin G20210A and MTHFR and recurrent fetal loss in a case-control study. Methods: Women aged 22-45 with a history of three or more fetal losses, being seen at a perinatal medicine clinic in New Jersey or Georgia, were eligible as cases. Overall, the study consisted of 60 women with three or more fetal losses and 92 women with at least one successful pregnancy. Results: Factor V HR2 and MTHFR were not related to recurrent fetal loss. The prothrombin G20210A mutation appeared to confer an elevation in risk but the association was based upon small numbers and was not statistically significant (OR 4.8, 95% CI 0.50-47.2). Cases were 90% less likely to have the factor V Leiden mutation than controls (OR 0.10, 95% CI 0.01-0.81). Conclusions: Our study did not demonstrate that women who are carriers of the factor V, prothrombin, or MTHFR mutations are at higher risk of recurrent fetal loss than women without these mutations. In regards to factor V Leiden, the prevalence in our cases (1.7%) was not statistically different from the known population prevalence of 5%. However, the high prevalence in our controls (14%) was unusual. Factor V Leiden may protect against bleeding in early pregnancy.

AB - Objective: Recurrent fetal loss, defined as the occurrence of three or more consecutive spontaneous abortions regardless of previous live birth, is a condition that affects about 2% of all reproductive-aged women. The role of gene mutations in recurrent pregnancy loss is not fully understood. The present research examined the relationship between factor V Leiden, factor V HR2, prothrombin G20210A and MTHFR and recurrent fetal loss in a case-control study. Methods: Women aged 22-45 with a history of three or more fetal losses, being seen at a perinatal medicine clinic in New Jersey or Georgia, were eligible as cases. Overall, the study consisted of 60 women with three or more fetal losses and 92 women with at least one successful pregnancy. Results: Factor V HR2 and MTHFR were not related to recurrent fetal loss. The prothrombin G20210A mutation appeared to confer an elevation in risk but the association was based upon small numbers and was not statistically significant (OR 4.8, 95% CI 0.50-47.2). Cases were 90% less likely to have the factor V Leiden mutation than controls (OR 0.10, 95% CI 0.01-0.81). Conclusions: Our study did not demonstrate that women who are carriers of the factor V, prothrombin, or MTHFR mutations are at higher risk of recurrent fetal loss than women without these mutations. In regards to factor V Leiden, the prevalence in our cases (1.7%) was not statistically different from the known population prevalence of 5%. However, the high prevalence in our controls (14%) was unusual. Factor V Leiden may protect against bleeding in early pregnancy.

UR - http://www.scopus.com/inward/record.url?scp=0036021465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036021465&partnerID=8YFLogxK

U2 - 10.1080/jmf.11.3.176.182

DO - 10.1080/jmf.11.3.176.182

M3 - Article

C2 - 12380673

AN - SCOPUS:0036021465

VL - 11

SP - 176

EP - 182

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

IS - 3

ER -